Novel CD19/CD22 Bicistronic Chimeric Antigen Receptors Outperform Single or Bivalent Cars in Eradicating CD19+ CD22+, CD19-, and CD22- Pre-B Leukemia

被引：0
|
作者：
Qin, Haiying
Nguyen, Sang M.
Ramakrishna, Sneha
Tarun, Samiksha
Yang, Lila
Verdini, Nicholas Peter
Haso, Waleed
Fry, Terry J.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
810
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Semi-Quantitative Analysis of CD19 and CD22 Expression in B-Lymphoblastic Leukemia and Implications for Targerted Immunotherapy
    Rosenthal, Jaclyn
    Naqvi, Ammar S.
    Wertheim, Gerald
    Paessler, Michele
    Rheingold, Susan R.
    Thomas-Tikhonenko, Andrei
    Pillai, Vinodh
    BLOOD, 2017, 130
  • [32] Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro
    Herrera, L
    Farah, RA
    Pellegrini, VA
    Aquino, DB
    Sandler, ES
    Buchanan, GR
    Vitetta, ES
    LEUKEMIA, 2000, 14 (05) : 853 - 858
  • [33] Allogeneic CD19/CD22 CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia
    Phely, Laurent
    Hensen, Luca
    Faul, Christoph
    Ruff, Christer Alexander
    Schneider, Dina
    Bethge, Wolfgang Andreas
    Lengerke, Claudia
    JAMA ONCOLOGY, 2024, 10 (06) : 789 - 792
  • [34] Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR
    Kokalaki, Evangelia
    Ma, Biao
    Ferrari, Mathieu
    Grothier, Thomas
    Hazelton, Warren
    Manzoor, Somayya
    Costu, Eren
    Taylor, Julia
    Bulek, Anna
    Srivastava, Saket
    Gannon, Isaac
    Jha, Ram
    Gealy, Rosalind
    Stanczuk, Lukas
    Rizou, Tatiana
    Robson, Mathew
    El-Kholy, Mohamed
    Baldan, Vania
    Righi, Matteo
    Sillibourne, James
    Thomas, Simon
    Onuoha, Shimobi
    Cordoba, Shaun
    Pule, Martin
    MOLECULAR THERAPY, 2024, 32 (02) : 556 - 558
  • [35] 1 Study of CD19/CD22 Bispecific Chimeric Antigen Receptor (CAR) Therapy in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia (ALL)
    Schultz, Liora M.
    Davis, Kara L.
    Baggott, Christina
    Chaudry, Christie
    Marcy, Anne Cunniffe
    Mavroukakis, Sharon
    Sahaf, Bita
    Kong, Katherine A.
    Muffly, Lori S.
    Kim, Stephen
    Meyer, Everett H.
    Fry, Terry J.
    Qin, Haiying
    Miklos, David B.
    Mackall, Crystal L.
    BLOOD, 2018, 132
  • [36] Multi-antigen targeting of CD19, CD22 and TSLPR to prevent Ph-like ALL resistance
    Ross, Savannah
    Bagashev, Asen
    Schneider, Dina
    Hu, Peirong
    Tasian, Sarah
    Fry, Terry
    CANCER RESEARCH, 2020, 80 (16)
  • [37] CD19 and CD22-directed biespecific CAR for B-cell Acute Lymphoblastic Leukemia
    Zanetti, S. R.
    Velasco-Hernandez, T.
    Gutierrez-Aguera, F.
    Roca-Ho, H.
    Sanchez-Martinez, D.
    Petazzi, P.
    Torres, R.
    Molina, O.
    Torrebadell-Burriel, M.
    Vidriales-Vicente, M. B.
    Hrusak, O.
    Fuster, J. L.
    Juan, M.
    Bueno, C.
    Menendez, P.
    HUMAN GENE THERAPY, 2019, 30 (11) : A54 - A54
  • [38] A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors
    Satiro N De Oliveira
    Jiexin Wang
    Christine Ryan
    Sherie L Morrison
    Donald B Kohn
    Roger P Hollis
    Journal of Translational Medicine, 11
  • [39] A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors
    De Oliveira, Satiro N.
    Wang, Jiexin
    Ryan, Christine
    Morrison, Sherie L.
    Kohn, Donald B.
    Hollis, Roger P.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [40] A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL
    Zhao, Lijun
    Li, Shuhong
    Wei, Xiaoyi
    Qi, Xuexiu
    Liu, Dong
    Liu, Lei
    Wen, Feiqiu
    Zhang, Ji-shuai
    Wang, Feng
    Liu, Ze-lin
    Cao, Yu J.
    BLOOD, 2022, 140 (16) : 1790 - 1802
12345